Next Generation Therapies

- to reduce symptoms of mental illness and retrain the brain

Bruce S. McEwen, Ph.D., expert on Depression
Bruce S. McEwen, Ph.D.
September 13, 2012
Scientific Council Member Bruce S. McEwen, Ph.D., is one of the authors of a new study that supports the hypothesis that elevating glucocorticoid levels—a...
Jess G. Fiedorowicz, M.D., Ph.D., University of Iowa, expert on mood disorders
Dr. Fiedorowicz
August 07, 2012
Jess Fiedorowicz, M.D., Ph.D., an Assistant Professor in the Departments of Psychiatry, Epidemiology, and Internal Medicine at the University of Iowa, won the...
Fred H. Gage, Ph.D., Professor, Laboratory of Genetics, Salk Institute Expert on Depression
Fred H. Gage, Ph.D.
July 24, 2012
Two Brain & Behavior Research Foundation Scientific Council Members have announced promising results of clinical trials of a ketamine-alternative called...
Olivier Berton, Ph.D., a two-time NARSAD Young Investigator Grantee and Assistant Professor of Psychiatry at the University of Pennsylvania
Olivier Berton, Ph.D.
June 29, 2012
Elevated levels of a class of hormones called glucocorticoids have long been linked to anxiety disorders and depression. It is known that the presence of too...
Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for Brain Sciences, schizophrenia expert
Richard Keefe, Ph.D.
June 28, 2012
Brain & Behavior Research Foundation Scientific Council Member Richard Keefe, Ph.D., Director of the Schizophrenia Research Group at the Duke Institute for...

Pages

Subscribe to